Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids for NAFLD
NCT01277237Phase 3Completed
- Sponsor
- University of Edinburgh
- Start
- Sep 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in non-alcoholic fatty liver disease (NAFLD), sponsored by University of Edinburgh. Started Sep 2010; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT01277237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01277237.